Isolation and characteristics of Shiga toxin 2f-producing Escherichia coli among pigeons in Kyushu, Japan.
An increasing number of Shiga toxin 2f-producing Escherichia coli (STEC2f) infections in humans are being reported in Europe, and pigeons have been suggested as a reservoir for the pathogen. In Japan, there is very little information regarding carriage of STEC2f by pigeons, prompting the need for further investigation. We collected 549 samples of pigeon droppings from 14 locations in Kyushu, Japan, to isolate STEC2f and to investigate characteristics of the isolates. Shiga toxin stx 2f gene fragments were detected by PCR in 16 (2.9%) of the 549 dropping samples across four of the 14 locations. We obtained 23 STEC2f-isolates from seven of the original samples and from three pigeon dropping samples collected in an additional sampling experiment (from a total of seven locations across both sampling periods). Genotypic and phenotypic characteristics were then examined for selected isolates from each of 10 samples with pulsed-field gel electrophoresis profiles. Eight of the stx 2f gene fragments sequenced in this study were homologous to others that were identified in Europe. Some isolates also contained virulence-related genes, including lpfA O26, irp 2, and fyuA, and all of the 10 selected isolates maintained the eae, astA, and cdt genes. Moreover, five of the 10 selected isolates contained sfpA, a gene that is restricted to Shiga toxin-producing E. coli O165:H2 and sorbitol-fermenting Shiga toxin-producing E. coli O157:NM. We document serotypes O152:HNM, O128:HNM, and O145:H34 as STEC2f, which agrees with previous studies on pigeons and humans. Interestingly, O119:H21 was newly described as STEC2f. O145:H34, with sequence type 722, was described in a German study in humans and was also isolated in the current study. These results revealed that Japanese zoonotic STEC2f strains harboring several virulence-related factors may be of the same clonal complexes as some European strains. These findings provide useful information for public health-related disease management strategies in Japan.
Department of Health Science, Fukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Koichi
K
Murakami
Department of Health Science, Fukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Yoshiki
Y
Etoh
Department of Health Science, Fukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Sachiko
S
Ichihara
Department of Health Science, Fukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Eriko
E
Maeda
Department of Health Science, Fukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Shigeyuki
S
Takenaka
Department of Health Science, Fukuoka Institute of Health and Environmental Sciences, Dazaifu, Fukuoka, Japan.
Kazumi
K
Horikawa
Laboratory of Microbiology, Oita Prefectural Institute of Health and Environment, Oita, Oita, Japan.
Hiroshi
H
Narimatsu
Miyazaki Prefectural Institute for Public Health and Environment, Miyazaki, Miyazaki, Japan.
Kimiko
K
Kawano
Department of Microbiology, School of Pharmacy, Aichi Gakuin University, Chikusa-ku, Nagoya, Aichi, Japan.
Yoshiaki
Y
Kawamura
National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Kenitiro
K
Ito
D000818:Animals; D001715:Bird Diseases / Q000453:epidemiology / Q000382:microbiology*; D010856:Columbidae / Q000382:microbiology*; D004197:Disease Reservoirs / Q000382:microbiology; D004927:Escherichia coli Infections / Q000453:epidemiology / Q000382:microbiology / Q000662:veterinary*; D005243:Feces / Q000382:microbiology; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D058885:Multilocus Sequence Typing; D010802:Phylogeny; D022641:Shiga Toxin 2 / Q000096:biosynthesis / Q000235:genetics*; D054323:Shiga-Toxigenic Escherichia coli / Q000235:genetics / Q000302:isolation & purification*
D022641:Shiga Toxin 2